Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Myocardial Fibrosis and Deformation Kinetics After the Ross Procedure Using Cardiac MRI

14. november 2026 oppdatert av: Yomna Mahmoud Shokry Abdelrehim, Assiut University

Myocardial Tissue Characterization and Deformation Kinetics Following the Ross Procedure: A Prospective Multiparametric CMR Study

The Ross procedure entails pulmonary autograft replacement of the aortic valve, primarily indicated in pediatric and young adult cohorts presenting with severe aortic valve disease. Despite postoperative preservation of left ventricular ejection fraction (LVEF) on resting transthoracic echocardiography, a subset of recipients exhibits blunted peak oxygen consumption (peak VO2), subclinical electromechanical dyssynchrony, and ventricular arrhythmias.

Chronic severe aortic valve pathology induces distinct myocardial remodeling patterns. Chronic pressure overload (aortic stenosis) triggers concentric cardiomyocyte hypertrophy and diffuse interstitial fibrosis. Chronic volume overload (aortic regurgitation) induces eccentric left ventricular dilatation and extracellular matrix degradation with collagen disarray. Following surgical hemodynamic unloading, left ventricular mass regresses; however, the extent of diffuse interstitial collagen matrix resorption versus pure cardiomyocyte cellular volume regression remains uncharacterized in this demographic.

This prospective longitudinal study employs multiparametric cardiovascular magnetic resonance (CMR) imaging to evaluate myocardial tissue characterization and deformation kinetics in young adults undergoing the Ross procedure. Participants will undergo contrast-enhanced CMR at baseline and at 12 months postoperatively. Quantitative endpoints include native T1 mapping, extracellular volume fraction (ECV), indexed extracellular volume (iECV), and three-dimensional (3D) feature-tracking strain (global longitudinal, circumferential, and radial strain). The primary objective is to correlate the resolution of diffuse microscopic fibrosis with subclinical mechanical recovery, comparing remodeling trajectories between pressure-overloaded and volume-overloaded phenotypes.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Studietype

Observasjonsmessig

Registrering (Antatt)

44

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

The study population comprises patients presenting with severe primary aortic valve disease-specifically chronic pressure overload (severe aortic stenosis) or chronic volume overload (severe aortic regurgitation)-who are scheduled for an elective full-root Ross procedure (pulmonary autograft replacement of the aortic valve). Patients are recruited prospectively and are evaluated without a history of obstructive coronary artery disease, prior myocardial infarction, primary non-ischemic cardiomyopathy, or systemic connective tissue disorders.

Beskrivelse

Inclusion Criteria:

  1. Severe primary aortic valve stenosis, regurgitation, or mixed lesion scheduled for an elective Ross procedure.
  2. Informed written consent to participate in serial prospective imaging.

Exclusion Criteria:

  1. Documented coronary artery disease (≥ 50% stenosis or previous coronary revascularization).
  2. Prior myocardial infarction or primary non-ischemic cardiomyopathy.
  3. Severe renal impairment (estimated Glomerular Filtration Rate < 30 mL/min/1.73 m²).
  4. Associated congenital heart disease causing volume overload ex: VSD and PDA.
  5. Systemic connective tissue disorders (Marfan, Loeys-Dietz, or Ehlers-Danlos syndromes).
  6. Standard contraindications to contrast-enhanced CMR (incompatible ferromagnetic implants, severe claustrophobia).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Diffuse myocardial fibrosis
Tidsramme: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Quantify the serial longitudinal changes in diffuse myocardial interstitial fibrosis-measured by indexed extracellular volume (iECV, in mL/m²)-from baseline to 12 months postoperatively in young adults undergoing the Ross procedure.

Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
Diffuse myocardial fibrosis
Tidsramme: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Quantify the serial longitudinal changes in diffuse myocardial interstitial fibrosis-measured by extracellular volume fraction (ECV, in %)

Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Subclinical myocardial mechanical recovery
Tidsramme: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Measured by 3D CMR feature-tracking strain analysis by 3D global longitudinal strain (3D-GLS)

Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
Subclinical myocardial mechanical recovery
Tidsramme: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Measured by 3D CMR feature-tracking strain analysis by 3D global circular strain (3D-GCS)

Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
Subclinical myocardial mechanical recovery
Tidsramme: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Measured by 3D CMR feature-tracking strain analysis by global radial strain [GRS].

Baseline up to two weeks before ROSS procedure and 1 year postoperatively.
Subclinical myocardial mechanical recovery
Tidsramme: Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Measured through 3D CMR feature-tracking strain analysis by peak diastolic strain rate.

Baseline up to two weeks before ROSS procedure and 1 year postoperatively.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. mai 2027

Primær fullføring (Antatt)

1. desember 2028

Studiet fullført (Antatt)

1. desember 2028

Datoer for studieregistrering

Først innsendt

25. oktober 2026

Først innsendt som oppfylte QC-kriteriene

14. november 2026

Først lagt ut (Faktiske)

17. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

17. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • CMR-ROSS

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere